Determination of bezafibrate concentration by high performance liquid-chromatography in serum of rats treated with lead nitrate.
暂无分享，去创建一个
[1] A. Fadda,et al. HDL subfractions as altered in cancer patients. , 1995, Journal of pharmaceutical and biomedical analysis.
[2] L. Tessitore,et al. Cholesterol content in tumor tissues is inversely associated with high‐density lipoprotein cholesterol in serum in patients with gastrointestinal cancer , 1994, Cancer.
[3] L. Tessitore,et al. Altered pattern of lipid metabolism in patients with lung cancer. , 1992, Oncology.
[4] L. Tessitore,et al. Cholesterol metabolism in normal and neoplastic cell proliferation , 1991 .
[5] A. Fadda,et al. Variations of serum lipoproteins during cell proliferation induced by lead nitrate. , 1989, Experimental and molecular pathology.
[6] C. Chiodino,et al. Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. , 1986, Experimental and molecular pathology.
[7] V. Monzani,et al. Determination of bezafibrate in human plasma and urine by high-performance liquid chromatography. , 1985, Journal of chromatography.